We are live on ! Find out more
IMA

ImageneBio Inc
IMA

33 hedge funds and large institutions have $69.8M invested in ImageneBio Inc in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

0.03% less ownership

Funds ownership: 72.38% → 72.35% (-0.03%)

21% less funds holding

Funds holding: 42 → 33 (-9)

25% less capital invested

Capital invested by funds: $93.2M → $69.8M (-$23.4M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
33
Holders Change
-9
Holders Change %
-21.43%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
9
Reduced
9
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.19M
2
CA
CHI Advisors
New York
+$1.13M
3
Verition Fund Management
Verition Fund Management
Connecticut
+$749K
4
State Street
State Street
Massachusetts
+$51.1K
5
Millennium Management
Millennium Management
New York
+$27.2K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.77M
2
HM
HealthCor Management
New York
-$781K
3
BlackRock
BlackRock
New York
-$524K
4
E
Ergoteles
New York
-$221K
5
Morgan Stanley
Morgan Stanley
New York
-$127K

IMA Hedge Fund Activity: Q4 2022 in Review

33 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2022, worth a combined $69.8M — down 25% from $93.2M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IMA and 2 opened new positions — a net loss of 8 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Fidelity Investments, adding an estimated $3.19M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $4.77M sold.

  • 33 institutional investors held ImageneBio Inc (IMA) as of Q4 2022, down from 42 in Q3 2022.
  • Funds reported $69.8M of ImageneBio Inc stock for Q4 2022, down 25% quarter-over-quarter.
  • 2 funds opened new ImageneBio Inc positions in Q4 2022 and 10 closed out, a net change of -8 holders.
  • The largest ImageneBio Inc buyer in Q4 2022 was Fidelity Investments, an estimated $3.19M added.
  • The largest ImageneBio Inc seller in Q4 2022 was Point72 Asset Management, an estimated $4.77M sold.

Based on aggregated 13F filings for Q4 2022.